ArticleFrontiers in medicine2021

Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation.

Gabriele Buda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.